Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review

Background: The deletion of exon 19 and the Leu858Arg mutation of exon 21 are the most frequently observed mutations in the epidermal growth factor receptor (EGFR) gene, and patients with these mutations have shown significant benefits from EGFR-tyrosine kinase inhibitors (TKIs). However, there exis...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Linlin, Huang, Siyuan, Qin, Liying, Yan, Ningning, Shen, Shujing, Li, Xingya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499621/
https://www.ncbi.nlm.nih.gov/pubmed/37719840
http://dx.doi.org/10.3389/fphar.2023.1257592

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10499621/
https://www.ncbi.nlm.nih.gov/pubmed/37719840
http://dx.doi.org/10.3389/fphar.2023.1257592

Ejemplares similares